Medications for diabetes and weight loss
Pro Research Analysisby 
Searched over 200M research papers
Diabetes Medications and Weight Loss: Key Drug Classes
Managing diabetes often involves addressing both blood sugar control and body weight, as obesity is a common comorbidity in type 2 diabetes and increasingly in type 1 diabetes as well. Several diabetes medications have been shown to help with weight loss, while others may cause weight gain or have a neutral effect on weight. Understanding these differences is important for optimizing treatment in people with diabetes who are also overweight or obese.
GLP-1 Receptor Agonists and Dual Agonists: Strongest Weight Loss Effects
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as liraglutide and semaglutide are among the most effective diabetes medications for weight loss, with studies showing they can lead to significant reductions in body weight—often greater than 5% of initial weight in people with type 2 diabetes 1259. The dual GLP-1/GIP receptor agonist tirzepatide has demonstrated even greater weight loss, with reductions ranging from 5.4 to 12.9 kg in people with type 2 diabetes and up to 21.4% of body weight in real-world use among people with type 1 diabetes 157. These medications also improve blood sugar control and reduce cardiovascular risk factors 579.
SGLT-2 Inhibitors: Moderate Weight Loss
Sodium-glucose cotransporter-2 inhibitors (SGLT-2i), including canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, are associated with moderate weight loss (typically between 3.2% and 5% of initial weight) in people with type 2 diabetes 1269+1 MORE. These drugs also provide cardiovascular and kidney benefits, making them a valuable option for many patients 910.
Metformin and Acarbose: Mild Weight Loss
Metformin, the first-line treatment for type 2 diabetes, and acarbose, an alpha-glucosidase inhibitor, both result in mild weight loss (less than 3.2% of initial weight) 1269+1 MORE. Metformin is widely used due to its effectiveness, safety, and cost, and is often the foundation of diabetes therapy .
DPP-4 Inhibitors and Other Agents: Neutral or Mild Effects
Dipeptidyl peptidase-4 (DPP-4) inhibitors generally have a neutral or only mild effect on weight 210. Some older medications, such as sulfonylureas, thiazolidinediones, and insulin, are associated with weight gain and are less preferred for patients who are overweight or obese 4610.
Weight Loss Medications Used in Diabetes
Some anti-obesity medications, such as orlistat and phentermine-topiramate, have been studied in people with diabetes. Orlistat and sibutramine (now withdrawn in many countries due to safety concerns) produced modest weight loss in clinical trials 38. Other agents like naltrexone-bupropion and pramlintide have also been considered, especially in type 1 diabetes, but more research is needed to confirm their safety and effectiveness .
Considerations for Individualized Diabetes and Weight Management
When choosing diabetes medications for people who are overweight or obese, it is important to consider the weight effects of each drug, as well as their impact on blood sugar, cardiovascular health, and side effect profiles 46910. Newer agents like GLP-1 RAs, SGLT-2 inhibitors, and tirzepatide are increasingly favored for their dual benefits in glucose and weight control 1256+3 MORE.
Conclusion
Several diabetes medications can help with weight loss, with GLP-1 receptor agonists, dual GLP-1/GIP agonists like tirzepatide, and SGLT-2 inhibitors showing the most promise. Metformin and acarbose offer mild weight loss, while DPP-4 inhibitors are generally weight-neutral. Choosing the right medication can help improve both blood sugar control and weight management, leading to better overall health outcomes for people with diabetes.
Sources and full results
Most relevant research papers on this topic